So their terrible 14c target is based on their assumpyions we will raise capital after results. Yet they go on to say any any data warranting further research will likely get US partner interest as theres nothing much happening re competition with solid efficacy. We have cash runway well into first half 25cy.
They also expect we'll need a third trial for approval but then talk of low fda approval bars giving sarepta examples, saying lobby groups there have a big influence and if our results were awesome approval is likely. They dont mention the word partial approval which I assume is where we will land.
id love to know their price target if they assume partnership and partial approval.
- Forums
- ASX - By Stock
- per-chart
So their terrible 14c target is based on their assumpyions we...
-
- There are more pages in this discussion • 434 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PER (ASX) to my watchlist
(20min delay)
|
|||||
Last
10.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $94.66M |
Open | High | Low | Value | Volume |
10.5¢ | 10.5¢ | 9.8¢ | $58.09K | 574.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 38503 | 10.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
10.5¢ | 194063 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 100000 | 0.099 |
2 | 108491 | 0.098 |
1 | 30927 | 0.097 |
1 | 10004 | 0.096 |
3 | 162157 | 0.095 |
Price($) | Vol. | No. |
---|---|---|
0.105 | 194063 | 5 |
0.110 | 254663 | 3 |
0.115 | 1334300 | 6 |
0.120 | 381142 | 9 |
0.125 | 110429 | 2 |
Last trade - 16.10pm 04/10/2024 (20 minute delay) ? |
Featured News
PER (ASX) Chart |